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Abstract
Phenylketonuria (PKU) is one of the most common human inborn errors of metabolism,
caused by phenylalanine hydroxylase deficiency, leading to high phenylalanine and low
tyrosine levels in blood and brain causing profound cognitive disability, if untreated. Since
1960, population is screened for hyperphenylalaninemia shortly after birth and submitted to
early treatment in order to prevent the major manifestations of the disease. However, the
dietetic regimen (phenylalanine free diet) is difficult to maintain, and despite the recommen-
dation to a strict and lifelong compliance, up to 60% of adolescents partially or totally aban-
dons the treatment. The development and the study of new treatments continue to be
sought, taking advantage of preclinical models, the most used of which is the PAHenu2
(BTBR ENU2), the genetic murine model of PKU. To date, adult behavioral and neurochem-
ical alterations have been mainly investigated in ENU2 mice, whereas there are no clear
indications about the onset of these deficiencies. Here we investigated and report, for the
first time, a comprehensive behavioral and neurochemical assay of the developing ENU2
mice. Overall, our findings demonstrate that ENU2 mice are significantly smaller than WT
until pnd 24, present a significant delay in the acquisition of tested developmental reflexes,
impaired communicative, motor and social skills, and have early reduced biogenic amine
levels in several brain areas. Our results extend the understanding of behavioral and cere-
bral abnormalities in PKU mice, providing instruments to an early preclinical evaluation of
the effects of new treatments.
Introduction
Phenylketonuria (PKU; McKusick2610600) is the most common metabolic inherited disease
caused by a deficiency in phenylalanine (Phe) metabolism, resulting in high Phe and low
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tyrosine levels [1] and in a wide range of symptoms among wich the most common is learning
disability [2, 3].
Since 1960, newborn screening and early treatment (a Phe-free diet) have considerably
improved outcomes, such that early treated children can lead nearly normal lives. Treatment
consists in a low-protein diet supplemented with generally unpleasant Phe-free mixture of
amino acids and nutrients that must be consumed in large amount. Although this is still the
best therapeutic option, the diet involves major alterations of the lifestyle, and patients and
their families experience difficulty in maintaining compliance to dietetic regimen. Moreover,
dietary therapy can be associated with deficiencies of several nutrients, some of which may be
harmful to brain development, and consolidated evidence indicates that even early-treated
PKU patients show cognitive deficits caused by mildly elevated blood Phe levels [4, 5, 6, 7].
Despite the recommendation to stay on dietary treatment for as long as possible, the compli-
ance to the diet gradually decreases after infancy. By adolescence, 60 to 80% of the patients
have abandoned the treatment, partially or totally.
The pressure created by these difficulties has renewed the interest in identifying different
approaches. During past years, treatment strategies alternative to the diet (e.g. sapropterin
dihydrochloride administration, supplementation with large neutral amino acids, gene ther-
apy, treatment with Phenylalanine ammonia lyase) have been proposed and submitted to pre-
clinical studies [8, 9, 10, 11] and clinical trials [12, 13, 14].
The development and the study of new treatments take advantage of preclinical models, the
most used of which is the PAHenu2 (ENU2), the genetic murine model of PKU. The chemically
induced genetic mutation [15] in the chromosome coding for PAH in this model results in a
phenotype closely resembling untreated human PKU, being characterized by reduced PAH
activity, PHE plasma levels 10–20 times higher than those of healthy littermates, hypomyelina-
tion, behavioral and neurochemical deficits [16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28].
To be efficacious, PKU treatment must start as soon as possible in the early days of life in
order to prevent neurodevelopmental perturbations [29].
Previously, we identified the 3rd week of postnatal life as a critical window of brain amine
availability in ENU2 mice [22] demonstrating that some behavioral and morphological abnor-
malities can be rescued by restoration of serotoninergic brain levels between postnatal day
(pnd) 14 and 21 [28]. This time window is also critical for synapse formation, dendritic growth
and remodelling, axonal refinement and columnarization in rodent cortices [30, 31, 32, 33].
Those data together made it possible to identify a critical period for brain development and
thus for therapeutic interventions.
However, to the best of knowledge, no data are available on the behavioral phenotype of
ENU2 mice during early postnatal life, as studies focused on adult animals [16, 23, 24, 27, 28, 34].
In order to investigate early behavioral abnormalities in ENU2 mice, we conducted a large
set of behavioral phenotyping assay in both males and females of healthy and mutant mice. In
particular, we evaluated body measurements, communicative behavior, developmental mile-
stones acquisition, neonatal social recognition, and motor skills development.
Results showed that ENU2 mice are significant smaller than WT, have a different pattern of
ultrasonic vocalizations and have a significant delay on the acquisition of several developmen-
tal reflexes, never reaching controls’ score in most of them. ENU2 mice also result to have
impaired motor and social skills: significant differences were indeed found compared to WT
in velocity and distance moved, and in Homing Test ENU2 spend less time in maternal bed-
ding area.
Neurotransmitters level deficits supports behavioral alterations; the biogenic amine levels
were found to be reduced in several brain structures in ENU2 pups, with serotonin (5-HT)
being the most affected one, as already shown in adult mice.
Early neurobehavioral alterations in PKU
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Our results extend the understanding of brain and behavioral abnormalities in ENU2 mice,
providing instruments to evaluate early the effects of new treatments.
Materials and methods
Animals
All experiments were conducted per the Italian Law (D. Lgs. 26/14) and the European Com-
munities Council Directive of November 24, 1986 (86/609/EEC) regulating the use of animals
for research.
All experiments of this study were approved by the ethics committee of the Italian Ministry
of Health and therefore conducted under license/approval ID #: 10/2011-B, according with
Italian regulations on the use of animals for research (D. Lgs. 26/14) and NIH guidelines on
animal care. Heterozygous multiparous females (+/-) were mated with heterozygous males to
obtain -/- ENU2 or +/+ Wild type (BTBR) offspring. Ten days after breeding females were
individually housed; delivery day was considered as pnd 0. Nine litters were used, and those
made of less than 6 and more than 10 pups were excluded from the experiment. In order to
investigate gender-related effects and reduce variability, as well as based on our previous expe-
rience maximum 10 animals for sex (M, F) were used for all experiments. All pups were equally
manipulated but only the score obtained by two male and female pups per litter were ran-
domly chosen to be included in the statistics, in order to be sure that all the litters were equally
represented. The experimenters were unaware of genotypes until pnd 10–12, when ENU2
mice become recognizable from the fur.
Before the beginning of the tests (pnd 3) mice were marked through distal phalanx removal,
in order to be recognizable during the whole testing period. For genotyping, tail biopsy was
performed; DNA was prepared using the Easy DNA Kit (Invitrogen, Carlsbad, CA, USA), and
the PAH mutation on exon 7 was detected by PCR amplification and digestion thought restric-
tion enzyme BsmAI (NewEnglandBiolabs, Inc., U.S.).
Behavioral assessment begun on pnd 4 and finished on pnd 18; animals were then weaned
on pnd 28. When possible every tested pup underwent the complete test battery, in order to be
able to follow its development.
On pnd 14 six behaviorally naïve male and female pups per strain were sacrificed through
decapitation and the brains collected, immediately frozen into liquid nitrogen and stored at
-80˚ until the biochemical analysis.
During mating and breeding mice were provided with food and water ad libitum and were
on a 12:12-h dark:light cycle (lights on from 7 AM to 7 PM) and everything was made to mini-
mize animals discomfort.
Body growth
Body weights and lengths of pups were measured to investigate offspring growth on pnd 5, 8,
11, 14, 17, 21, 24 and 28 (Fig 1). Data were analyzed by two-way ANOVA for repeated mea-
sures (genotype, 2 levels: WT and ENU2 as the between-group factor; age, 8 levels: 5, 8, 11, 14,
17, 21, 24, and 28 as within-group factor; WT: 8 female and 9 male; ENU2: 7 female and 7
male) followed by post-hoc Duncan’s test for multiple comparisons.
Ultrasound emissions evaluations (USVs)
The ultrasound emission is the main communicative behavior pups display to elicit maternal
care. Abnormalities in the typical emission pattern might underlie damaged mother-pup
bound, anxiety problems and development impairment. From pnd 4 to 14 to evaluate
Early neurobehavioral alterations in PKU
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ultrasounds, after an hour acclimatization in the testing room, pups were firstly separated
from the mother and after 5 min individually placed in a clean beaker covered with clean saw-
dust and the emissions recorded for five minutes. To prevent cooling, pups were maintained
on a hot plate (36˚) and after recording they were returned to the home cage. No more than
5–6 pups per litter were tested [35].
The registration apparatus, shown in Fig 2A, consisted of an UltraSoundGate Condenser
Microphone (CM16, Avisoft Bioacoustics, Berlin, Germany), sensitive to frequencies of 15–
180 kHz, with a flat frequency response (± 6 dB) between 25–140 kHz, was placed 1 cm above
the beaker and connected to a computer that recorded data as 250,000 Hz in 16-bit format wav
files. Sound files were transferred to SASLab Pro (version 5.2; AvisoftBioacoutics) for sono-
graphic analysis, and fast Fourier transformation was conducted (512 FFT-length, 100%
frame, Hamming window, and 75% time window overlap). Spectrograms were produced at
488 Hz frequency resolution and 0.512 ms time resolution. To detect USVs, an automatic
threshold-based algorithm and a hold time mechanism (hold time: 20 ms) were used. Signals
below 40 kHz were truncated to reduce background noise to 0 dB [36]. Inaccurate detections
were adjusted manually by an experienced user [37]. We analyzed the curve of the number of
calls during development and on pnd 6 we focused on different features of the calls, such as
mean duration, number, mean peak frequency, mean peak amplitude, modulation and total
time spent calling.
The curve of the number of USVs emitted was analyzed by two-way ANOVA for repeated
measures (genotype, 2 levels: WT and ENU2 as between-group factor; age, 4 levels: 6, 8, 10, 12
as within-group factor; (WT: females and 6 males; ENU2: 5 females and 5 males) followed by
post-hoc Duncan’s test for multiple comparisons. The analysis of the USVs features on pnd 6
was performed by one-way ANOVA to evaluate the genotype effect (WT: 8 females and 8
males; ENU2: 7 females and 7 males).
Fig 1. Body growth. Representative photograph (a) of WT (left) and ENU2 (right) mice showing body size differences at
pnd 24. Analysis of weight (b) and length (c) of WT and ENU2 from pnd 5 to weaning at pnd 28. Significant differences in
body weight were found on pnd 18, 21, 24 and 28, and in length on pnd 21, 24 and 28, ENU2 being smaller than controls.
Data are expressed as mean ± SEM. *p < .05, **p < .01, ***p < .001 WT vs ENU2.
https://doi.org/10.1371/journal.pone.0183430.g001
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Developmental reflex acquisition
From pnd 5 to pnd 17 sensorimotor reflexes such as righting reflex, negative geotaxis, screen
test, vertical screen test, auditory startle, cliff avoidance, vibrissae stimulation reflex, visual
placing response, were recorded [38, 39].
Fig 2. Ultrasound emission analysis. Apparatus (a) and number of vocalization on pnd 4, 6, 8, 12 and 14
(b). Significant strain differences were found on pnd 6 and 8; ENU2 pups never reach the peak present in WT.
Analysis of duration (c), number (d), mean peak frequency (e), mean peak amplitude (f), modulation of calls
(g) and time spent calling (h) at pnd 6 in response to maternal separation in WT and ENU2 pups. ENU2 emit
less calls ad spend less time calling in total, but the emissions are higher in frequency and amplitude. Data are
expressed as mean ± SEM. *p < .05, **p < .01, ***p < .001 WT vs ENU2.
https://doi.org/10.1371/journal.pone.0183430.g002
Early neurobehavioral alterations in PKU
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The parameters analyzed were the latency to act out the behavior (righting reflex and nega-
tive geotaxis) or the score obtained on a four level scale (0 = no response; 1 = weak response;
2 = incomplete response; 3 = complete/adult-like response)
If no response was present within 30 seconds, the animal was given 0 points, or 30” (cut off
time) in the latency evaluation.
Development of reflexes was analyzed by two-way ANOVA for repeated measures (geno-
type, 2 levels: WT and ENU2 as between-group factor; age, 5 levels: 5, 8, 11, 14, 17 for each
reflex, as within-group factor (WT: 12 female and 10 male WT; ENU2: 11 female and 12 male)
followed by post-hoc Duncan’s test for multiple comparisons.
Homing Test
Pups were tested on pnd 10. After an hour habituation in the testing room, mothers were
removed from the home cages and placed on a hot plate (36˚) to prevent offspring cooling.
The test started after 5 min separation.
The testing apparatus was made of a central compartment and 2 lateral arms (31 cm x 4 cm
with walls 6 cm in height), one covered with home cage bedding, the other with clean sawdust.
Pups were individually placed in the empty center and, after 1 minute of habituation, they had
to choose between the two arms. Time spent into the arm containing the nesting litter, per-
centage of maternal arm choices, latency to reach maternal and zone crossings were scored
[35, 39, 40].
A video-based EthoVision system (Noldus, The Netherlands) was used to record and ana-
lyze the data. Statistical analysis was performed by one-way ANOVA to evaluate the effect of
the genotype on the parameters (WT: 8 female and 9 male; ENU2: 7 female and 7 male).
Open Field
Animals underwent the Open Field test on pnd 18 to evaluate motor skills development.
Pups were individually tested for five minutes [39, 41, 42]. Distance moved (cm) and veloc-
ity (cm/sec) were used as dependent variables. To record and analyze the data we used the
EthoVision system (Noldus, The Netherlands) was used.
Statistical analysis was performed by one-way ANOVA (WT: 8 female and 9 male; ENU2: 7
female and 8 male) to evaluate the effect of genotype on the parameters.
Neurotransmitters analysis
Punches were obtained as previously described [25]. Frozen brains were sliced (coronal sec-
tions) and punches of the mpFC, CP, Amy, NAc, and Hip were made with stainless steel tubes
of 0.8, 1.0, or 1.5 mm inside diameter.
The punches were stored in liquid nitrogen until the day of the analysis.
Frozen samples were weighed and homogenized in 0.05 M HClO4. The homogenates were
centrifuged at 14000 rpm for 20 min at 4˚C. Tissue levels of 5-HT, DA, NE and their metabo-
lites 5-HIAA, DOPAC, HVA and MHPG were assessed using HPLC system [25]. The HPLC
system consists of an Alliance (Waters) system and a coulometric detector (ESA Model 5200A
Coulochem II) provided with a 5011 high sensitivity analytical cell and a 5021 conditioning
cell, the potential being set at .450mV and .100 mV, respectively. The column, a Nova-Pack
Phenyl column and a Sentry Guard Nova-Pack pre-column, were purchased from Waters
Assoc. The flow rate was 1 ml/min. The mobile Phase consisted of 3% methanol in 0.1M Na-
phosphate buffer pH 3, 0.1mM, Na2 EDTA and 0.5mM 1-octane sulphonic acid Na salt. Statis-
tical analysis of for the effect of genotype on the single structure and compound was performed
by one-way ANOVA.
Early neurobehavioral alterations in PKU
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Results
Since no significant difference between male and female was found in all the tests, the results
are shown as sex-balanced groups.
Reduced body growth
Body growth was measured from pnd 5 to 28 (Fig 1A, 1B and 1C). Statistical analysis revealed
significant genotype x age interaction for weight (F(6,174) = 8,149; p<0.001; post hoc analysis p
< .05 and .001 for ENU2 to WT at pnd 18, 21 and 24; Fig 1B) and length (F(6,174) = 28,165;
p<0.001; post hoc analysis p< .001 and .05 for ENU2 to WT at pnd 21, 24 and 28; Fig 1C).
ENU2 pups are shorter and weight less than WT, and these differences become significant
at the beginning of the weaning, when maternal nourishing is reduced.
Reduced ultrasound emission
Measurements of ultrasonic emissions in separated pups (curve of emissions from pnd 4 to
pnd 14 Fig 2B; pnd 6, Fig 2C, 2D, 2E, 2F, 2G and 2H) showed significant differences between
WT and ENU2 mice. Two-way ANOVA revealed significant genotype x age interaction for
the number of calls (F(5,100) = 2,898; p<0,05; post hoc analysis p< .001 for ENU2 to WT at
pnd 6 and 8): ENU2 pups emit significant fewer calls and never reach the peak present in WT
calls, although a curve of emissions is still present.
One-way ANOVA revealed that at pnd 6 ENU2 mice emit less calls in comparison with
WT (F(1,28) = 14,788; p<0,001), the calls emitted have a higher mean peak frequency (F(1,28) =
7,971; p<0,01) and a lower mean peak amplitude (F(1,28) = 11,063; p<0,01), and, even if the
difference in the mean duration of the calls is not significant, the total amount of time spent
calling is significantly lower (F(1,28) = 13,539; p<0,001).
Delay in the developmental reflex acquisition
Fig 3 shows the acquisition of early (from pnd 5 to 17) developmental reflexes in ENU2.
Righting reflex. (Fig 3A), that is the latency to turn over to the upright position when
placed on the back, was tested at pnd 5 to 17 in both groups. Statistical analysis revealed a sig-
nificant genotype x age interaction on righting reflex latency (F(4,168) = 7,783; p<0.001; post
hoc analysis p< .001 and .05 for ENU2 to WT at 5, 8 and pnd 11).
Negative geotaxis. (Fig 3B), that is the latency to change the orientation when placed on
an inclined plan, was tested at pnd 8 to 17 in ENU2 ant WT mice. Statistical analysis revealed a
significant genotype x age interaction (F(3,126) = 2,676; p<0.05; post hoc analysis p< .05 for
ENU2 to WT at pnd 14)
Cliff avoidance. (Fig 3C), the ability of the pup to moving away when placed on the edge
of a raised platform, was recorded from pnd 8 to 17 and statistical analysis revealed significant
genotype effect (F(1,126) = 45,504; p< .001) but no significant interaction with age.
Auditory startle. (Fig 3D), i.e. the response to acoustic stimuli, was recorded from pnd 8
to pnd 17, and statistical analysis showed a significant genotype x age interaction (F(3,126) =
24,771; p<0.001; post hoc analysis p< .001 for ENU2 to WT at pnd 14 and 17).
Vibrissa placing response. (Fig 3E), measured from pnd 8 to 17 by evaluating the
response of pup to raise head and forelimbs to grasp a cotton swab after vibrissae stimulation,
revealed only a significant genotype (F(1,126) = 5,777; p< .05) and age effect (F(3,126) = 23,177;
p< .001).
Placing reflex. (Fig 3F), i.e. ability of the pup to rise his head and extend the forelimbs
toward a solid surface after being suspended by the tail, has been measured from pnd 8 to 17,
Early neurobehavioral alterations in PKU
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Fig 3. Developmental reflex assay. Analysis of acquisition of the somatosensorial reflex righting (a), negative
geotaxis (b), cliff avoidance (c) auditory startle (d), vibrissae stimulation reflex (e), visual placing response (f),
screen test (g), vertical screen test (h) in WT and ENU2 mice on pnd 5, 8, 11, 14 and 17. ENU2 show delayed
acquisition of all tested reflexes, indicating impaired motor and sensory skills. Data are expressed as mean ± SEM.
*p < .05, **p < .01, ***p < .001 WT vs ENU2.
https://doi.org/10.1371/journal.pone.0183430.g003
Early neurobehavioral alterations in PKU
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and statistical analysis revealed significant genotype x age interaction (F(3,126) = 20,330;
p<0.001; post hoc analysis p< .01 and .05 at pnd 8 and 17).
Level screen test. (Fig 3G) has been analyzed by measuring from pnd 8 to 17 if the pup
can hold onto a screen when it is horizontally dragged by the tail across it, and statistical analy-
sis showed significant genotype x age interaction (F(3,126) = 65,192; p<0.001; post hoc analysis
p< .05 and .001 pnd 11 and 17).
Vertical screen test. (Fig 3H) measures the climbing response of the pup when the wire
mesh screen in which is placed is rotated in a vertical position; the ANOVA revealed signifi-
cant effect of genotype x age interaction (F(3,126) = 6,042; p<0.001; post hoc analysis p< .05
and .001 at pnd 14 and 17).
Altogether, analyzed data showed that ENU2 mice have impairments in almost all tested
skills, showing a motor and sensory developmental delay.
Alterations in the Homing Test
A significant genotype effect was found on the percentage of the choice of the area containing
maternal litter sawdust (Fig 4A, 4B, 4C, 4D and 4E). ANOVA demonstrated that ENU2 10-day-
old pups spent less time in the nest area in comparison with WT (F(1,29) = 14,135; p<0,05); also
the percentage of entries in the nest area was significantly different (F(1,30) = 5,309; p< .001).
Significant genotype effect was also found in latency of entries in the maternal area (F(1,35) =
6,516; p< .05), likewise significant was the difference in the entries in the non-maternal area
(F(1,29) = 13,147; p< .01) shown after the analysis of the apparatus zone crossing.
Deficits in the Open Field Test
Locomotor activity of 18-day-old pups in an empty Open Field was lower in ENU2 mice com-
pared to WT (Fig 5A, 5B and 5C). In particular, statistical analysis revealed significant geno-
type effect on velocity (F(1,30) = 9,250; p<0,01) and distance moved (F(1,30) = 9,213; p<0,01)
parameters, showing that at pnd 18 ENU2 are significantly slower and move less than healthy
control mice.
Center time in the apparatus did not differ between groups.
Early neurochemical abnormalities
Results from analysis of neurotransmission in different brain areas (medial prefrontal Cortex,
mpFC; Nucleus Accumbens, NAC; Caudate Putamen, CP; Hippocampus, HIPP; Amygdala,
AMY) are reported in Table 1.
Data are indicated as mean concentrations of biogenic amines (dopamine, DA; norepineph-
rine, NE; 5-hydroxytryptamine, 5-HT) and metabolites (3-4-Dihydroxyphenylacetic acid,
DOPAC; homovanillic acid, HVA; 3-methoxy-4 hydroxyphenylethyleneglycol, MHPG;
5-hydroxyindoleacetic acid, 5-HIAA) ±ES.
One-way ANOVAs revealed a significant genotype effect for almost all amines in all investi-
gated brain areas, with the exception of NE in mpFC, Hipp and NAC and of DA in CP and
HIPP.
As previously evidenced (25, 22, 23, 24), the levels of 5-HT and of its metabolite 5-HIAA
were early and significantly reduced in ENU2 mice regardless of the brain areas.
Discussion
In a murine model of a metabolic inherited disease it is essential to analyze behavioral and
neurochemical phenotyping during the early developmental period in order to identify the
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exact onset of behavioral symptoms and brain alterations, and then to indicate the best time
for early intervention and what parameters to keep an eye on during preclinical evaluation of
experimental treatments. To date, although behavioral and neurochemical alterations have
been extensively demonstrated in adult mice [34, 43], this study is the first to report the onset
of these deficiencies, providing a comprehensive behavioral and neurochemical assay of the
developing ENU2 mouse, the best murine model of PKU. Our study shows that ENU2 mice
reach many developmental milestones later than their healthy littermates. First of all, in
mutant mice body weight and length were reduced during the third postnatal week. This result
is in line with several reports suggesting that growth in early childhood in PKU is reduced in
comparison with reference populations [44], as well as with a previous preclinical report
Fig 4. Homing Test. Homing test apparatus (a) and analysis of differences in time spent in maternal area (b), % of
maternal area entries (c), latency to reach maternal (d) and zone crossing (e) in WT and ENU2 pups on PND 10.ENU2
performances are significantly worse than WT, indicating slower development of social cognitive abilities. Data are
expressed as mean ± SEM. *p < .05, **p < .01, ***p < .001 WT vs ENU2.
https://doi.org/10.1371/journal.pone.0183430.g004
Early neurobehavioral alterations in PKU
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Fig 5. Open Field. Open Field apparatus (a) and analysis of the differences between WT and ENU2 in velocity (b) and
distance moved (c). ENU2 were found to be slower and moved less than WT. Data are expressed as mean ± SEM. **p <
.01 WT vs ENU2.
https://doi.org/10.1371/journal.pone.0183430.g005
Table 1. Biogenic amines and metabolites tissue levels (ng/g wet weight) in different brain areas of BTBR and ENU2 mice at PND 14.
Area
mpFC CP Amy Hipp NAc
5-HT WT 36 ± 8 532 ± 111 122 ± 36 50 ± 6 31 ± 8
ENU2 10 ± 2 *** 241 ± 71* 26 ± 7** 17 ± 4*** 5 ± 2**
5-HIAA WT 78 ± 10 568 ± 115 1662 ± 458 429 ± 110 300 ± 72
ENU2 13 ± 2*** 61 ± 9*** 374 ± 50** 148 ± 26*** 29 ± 6**
NE WT 118 ± 11 71 ± 8 189 ± 39 306 ± 43 1282 ± 479
ENU2 81 ± 15 37 ± 8** 91 ± 18* 185 ± 42 316 ± 78
MHPG WT 5 ± 1 4 ± 1 32 ± 7 - 209 ± 237
ENU2 4 ± 1 1 ± 0, 4* 18 ± 2 - 97 ± 50
DA WT 112 ± 11 1836 ± 476 264 ± 80 108 ± 46 2879 ± 990
ENU2 20 ± 3* 1357 ± 191 79 ± 21* 111 ± 30 614 ± 185**
DOPAC WT 7 ± 1 364 ± 63 97 ± 35 56 ± 9 330 ± 48
ENU2 6 ± 1 354 ± 96 45 ± 9 52 ± 13 160 ± 43*
HVA WT 33 ± 4 272 ± 53 196 ± 59 162 ± 33 728 ± 177
ENU2 26 ± 4 296 ± 63 92 ± 18 114 ± 23 206 ± 40*
Almost all amine and metabolites result to be deficient in ENU2 in investigated areas, except NE in mpFC, Hipp and NAC and of DA in CP and HIPP; 5-HT
and 5-HIAA are the most affected ones in all areas.
Values are expressed as mean± ES.
* p<0,05,
** p<0,01,
*** p<0,001 BTBR vs ENU2.
https://doi.org/10.1371/journal.pone.0183430.t001
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showing reduced postnatal growth in ENU2 mice in comparison with heterozygous littermates
[45]. It should be noted that, although heterozygous ENU2 mice have been often used as con-
trol group instead of WT subjects, abolishing the costs of genetic characterization following
heterozygous mating, recent data have confirmed hyperphenylalaninemic status of heterozy-
gous ENU2 mice [24]. Therefore, the use of heterozygous mice as control group is questioned.
Mice emit and perceive Ultrasound Vocalizations (USVs) to communicate; in particular
USVs are emitted by pups when taken out from the nest and separated from their mother, to
induce maternal retrieval in the nest. Therefore, USVs are commonly used in preclinical stud-
ies to measure communication deficits in murine models of neurodevelopmental disorders.
We registered USVs from pnd 4 until pnd 14 to study the whole curve of emissions, and we
found that ENU2 pups never reach the peak present in WT calls. Since pnd 6 represents the
peak of emissions we decided to go deeper into the characterization. The analysis of different
parameters of the emissions at pnd 6 revealed that ENU2 pups emit less call, and even if the
mean duration of the calls did not differ between strains, the overall time spent calling is
reduced in ENU2; the calls are also “softer”, as indicate by the Amplitude and are more fre-
quent indicating also qualitative differences in the emissions. These data add another aspect to
the behavioral profile of EN2 mice, being communication damaged in both quantitative and
qualitative features.
Moreover, in every developmental milestones ENU2 mice showed a difference in compari-
son to WT in terms of reduced performance, in at least one time point. Generally, ENU2
reached fully developed reflexes later than healthy littermates, as showed by increased latency
or reduced scores obtained in many of them.
Homing Test allows investigating complex abilities, such as sensory and motor skills, odors
recognition and preference for social inputs. In the Homing Test, 10-day-old ENU2 pups
showed longer latency to reach, less time spent in and lower percentage of entries in the area
containing nesting odor, in comparison to WT. Although ENU2 pups present reduced loco-
motor activity, in the Homing Test they carry out a number of zone crossings comparable to
healthy littermates. Therefore, data suggest slower development of social olfactory and related
cognitive abilities as compared to control mice.
In addition, distance moved and velocity during the Open Field Test showed that 18-day-
old ENU2 pups had lower general activity than age-matched WT. These data are in agreement
with several previous studies showing reduced locomotor activity in adult animal model of
PKU [24, 34, 35, 43] and underline the precociousness of the deficit.
According to behavioral data, neurochemical analysis revealed early abnormalities in
14-day-old ENU2 pups. ENU2mouse brain is early characterized by relevant cerebral deficits,
with particularly dramatic deficiency in serotonergic metabolism, characterized by more than
50% of level reduction in all investigated brain areas. With respect to catecholamine reduction,
the presence and the seriousness of effects depend on the observed cerebral structure.
The brain amine reduction observed here is consistent with clinical and preclinical neuro-
chemical studies showing reduced aminergic metabolism in brain [46] and cerebrospinal fluid
[47, 48, 49] of PKU patients and in PKU mouse brain [43]. About prominent 5-HT deficits,
this is consistent with previous studies on amine synthesis in hyperphenylalaninemic organ-
isms, in adulthood [24, 25, 50, 51] as well as during early postnatal development [22, 28] in
ENU2 mice. Synthesis of 5-HT occurs via tryptophan hydroxylation to 5-hydroxy-tryptophan
by tryptophan hydroxylase enzyme. Reduced cerebral 5-HT synthesis may be the result of
reduced tryptophan brain concentrations caused by reduced blood-brain-barrier transport of
tryptophan or by reduced tryptophan hydroxylase activity at elevated, plasma or brain respec-
tively, Phe concentrations [3]. As a whole, the extent of early neurochemical effects can
account for several and early behavioral alterations observed in developing ENU2 mice.
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Present study identifies early behavioral and neurochemical alterations in the best murine
model of PKU, providing a comprehensive assay of the several deficits in young ENU2 mice,
as well as the parameters to keep an eye on during preclinical evaluation of alternative treat-
ments. Our data showing early behavioral and neurochemical characterization of ENU2
strengthens the face validity of the genetic murine model of PKU. Furthermore, these early
neurobehavioral alterations make possible, in the future, to evaluate precociously the effects of
alternative treatments, monitoring early stages of postnatal life in live hyperphenylalaninemic
mice.
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